These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 331821)

  • 1. Double blind trial with suloctidil, a new vasoactive agent, in elderly patients with psycho-organic brain syndrome.
    Jacquy J; Noel G
    Acta Clin Belg; 1977; 32(1):22-6. PubMed ID: 331821
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical pharmacology and therapeutic effect of suloctidil on intellectual and motor disorders of cerebrovascular origin].
    Soulairac A
    Acta Clin Belg; 1977; 32(1):27-35. PubMed ID: 331822
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of therapeutic effect of suloctidil in aged patients with cerebrovascular insufficiency. Double-blind study in comparison with placebo].
    Bargheon J
    Acta Clin Belg; 1977; 32(1):15-21. PubMed ID: 331820
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effectiveness of vasoactive preparations in patients with circulatory encephalopathy].
    Petelin LS; Shtok VN; Fedorova NV
    Klin Med (Mosk); 1988 Sep; 66(9):67-9. PubMed ID: 3204964
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blind study comparing suloctidil and placebo in chronic peripheral arteriopathy.
    Gillot P
    Curr Ther Res Clin Exp; 1976 Nov; 20(5):637-44. PubMed ID: 825349
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of cyclandelate on cerebral circulation. A double blind trial with clinical and radiocirculographic investigations.
    Eichhorn O
    Vasc Dis; 1965 Nov; 2(6):305-15. PubMed ID: 5323511
    [No Abstract]   [Full Text] [Related]  

  • 7. [Rational selection of vasoactive drugs for the treatment of patients with vestibular dysfunction].
    Boĭko NV
    Vestn Otorinolaringol; 1991; (5):42-7. PubMed ID: 1755185
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical evaluation of cinnarizine in patients with cerebral circulatory deficiency.
    Toledo JB; Pisa H; Marchese M
    Arzneimittelforschung; 1972 Feb; 22(2):448-51. PubMed ID: 4554633
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic use of a new vasoactive drug in cerebral vascular diseases in elderly patients].
    Petronio G; Scali G; Casa B; Nonis E
    Clin Ter; 1980 Aug; 94(4):427-44. PubMed ID: 6257445
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic action of vasodilator drugs in chronic cerebrovascular insufficiency].
    Chacón Peña J; Castellanos Mateos F
    Rev Clin Esp; 1978 Oct; 151(2):165-70. PubMed ID: 740988
    [No Abstract]   [Full Text] [Related]  

  • 11. [Management of cerebrovascular circulation disorders with Tropodil].
    Steinbach M
    Med Klin; 1967 Feb; 62(7):257-9. PubMed ID: 5595330
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic approach to TIA and acute cerebral stroke in geriatric patients using a platelet aggregation inhibiting and vasoactive drug].
    Cucinotta D; Monica C; Silvestrini C; Ceccato S; Cocchi C
    G Clin Med; 1979 Apr; 60(4):301-9. PubMed ID: 488589
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of cerebral vascular insufficiency syndromes in old age. Controlled research by double blind technic].
    Mars G; Nebuloni G
    G Gerontol; 1970 Mar; 18(3):153-76. PubMed ID: 4919664
    [No Abstract]   [Full Text] [Related]  

  • 14. Trials of 3,7-dimethyl-1-(5-oxohexyl) xanthine (BL 191) in double-blind tests.
    Buckert D; Harwart D
    Farmaco Prat; 1976 May; 31(5):264-74. PubMed ID: 773679
    [No Abstract]   [Full Text] [Related]  

  • 15. [Preliminary results in the modifications of cerebral blood flow using xenon-133 during administration of ginkgo-biloba].
    Agnoli A; Fiorani P; Pistolese GR
    Minerva Med; 1973 Nov; 64(79 Suppl):4166-73. PubMed ID: 4378392
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the role of vincamine in the therapy of cerebrovascular diseases and impairment of cerebral function (author's transl)].
    Witzmann HK; Blechacz W
    Arzneimittelforschung; 1977; 27(6a):1238-47. PubMed ID: 332190
    [No Abstract]   [Full Text] [Related]  

  • 17. [Double-blind study based upon a quatitative appreciation scale of treating chronic cerebrovascular disorders].
    Mémin Y; Najean Hueber E
    Therapeutique; 1973 Nov; 49(9):605-8. PubMed ID: 4600040
    [No Abstract]   [Full Text] [Related]  

  • 18. Double-blind trial of suloctidil versus placebo in moderate to severe mental deterioration.
    Baro F; Malfroid M; Waegemans T; Cox JP
    Pharmatherapeutica; 1985; 4(6):399-404. PubMed ID: 3001778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of cerebrovascular deficiencies. Therapeutic evaluation from 129 cases using the double-blind method against placebo].
    Bargheon J; Durocher AM; Lagrange M
    Sem Hop; 1984 Jan; 60(3):169-74. PubMed ID: 6320441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Principles of pharmacologic correction of neurologic disorders in initial atherosclerotic encephalopathy.
    Man'kovsky NB; Minz AY
    Gerontology; 1988; 34(1-2):75-81. PubMed ID: 3384341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.